Topical vs. intravenous administration of tranexamic acid in knee arthroplasty and prevalence of deep venous thrombosis: a randomized clinical trial

Topical vs. intravenous administration of tranexamic acid in knee arthroplasty and prevalence of deep venous thrombosis: a randomized clinical trial

Abstract Background Tranexamic acid (TXA) is widely used in orthopedic surgery to reduce perioperative bleeding. Since TXA inhibits fibrinolysis, there is concern that it may increase the risk of thromboembolic events. Objectives To verify the prevalence of deep venous thrombosis (DVT) in patients...

Full description

Bibliographic Details
Main Authors: Ari Zekcer, Ricardo Del Priori, Clauber Tieppo, Ricardo Soares da Silva, Nilson Roberto Severino
Format: Article
Language:English
Published: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
Series:Jornal Vascular Brasileiro
Subjects:
tranexamic acid
arthroplasty
knee replacement
fibrin modulating agents
antifibrinolytic agents
venous thrombosis
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492016000200120&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492016000200120&lng=en&tlng=en

Similar Items